adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
Published 7 years ago • 4.3K plays • Length 38:22Download video MP4
Download video MP3
Similar videos
-
22:48
adjuvant therapy of breast cancer
-
13:56
adjuvant therapy - chemotherapy issues
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
26:48
strategies for improving neoadjuvant therapy decision-making for her2 breast cancer
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
9:36
neoadjuvant therapy for hr breast cancer
-
10:52
debate: optimal neoadjuvant strategy in pancreatic cancer - preoperative chemotherapy radiation
-
19:44
emerging biomarkers and novel therapies for esophageal cancer
-
57:06
neoadjuvant endocrine therapy in breast cancer
-
1:22
analyzing predictors of response to neoadjuvant chemotherapy in breast cancer
-
0:29
adjuvant treatment for high risk hr breast cancer | esmo 2023 breast cancer highlights
-
0:35
unlocking the power of neoadjuvant therapy for breast health
-
2:31
adjuvant/neoadjuvant therapy trials for breast cancer at sabcs 2021
-
27:18
adjuvant and neoadjuvant dilemmas
-
3:11
st. gallen consensus 2021: neoadjuvant and adjuvant therapy for her2 breast cancer
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
3:12
neoadjuvant versus adjuvant therapy in tnbc
-
27:25
neoadjuvant and adjuvant treatment considerations of ilc | lobular breast cancer event 2023